Industry News

Inside the 2026 Medical Aesthetic Boom: PDRN’s Pivotal Role Take Center Stage.
2026-02-09
PDRN (Polydeoxyribonucleotide), a bioactive polymer from salmon DNA, is key in Regenerative Aesthetics, with 95% similarity to human DNA. Its high biocompatibility allows seamless bodily utilization, acting as a "natural spare part" for cellular repair, with Placentex® as an industry standard. PDRN’s multi-target bioactivity promotes skin renewal: repairing the barrier, stimulating collagen, reducing inflammation, and boosting microcirculation.
The 2026 Guide to Regenerative Aesthetics
2026-01-29
In 2026, the aesthetics industry is shifting from "external filling" to "internal regeneration". Simple volume replacement no longer meets high-end consumers’ demands, making Regenerative Aesthetics the industry’s core defining keyword. Powered by cutting-edge biotech breakthroughs, a regenerative system built on Biostimulator and multi-dimensional technological synergy is reshaping youth standards.
The New Masculine Aesthetic is Blooming
2026-01-20
As the beauty trend spreads, gender boundaries in the consumer market are breaking down. Medical aesthetics, once dominated by women, is now seeing a massive surge in male trends. A new revolution focused on natural and refined looks is happening. By 2026, the "Male Beauty Economy" has become a core engine for the industry’s growth.